Abstract
Nicotine, one of the compounds that alter brain function, has been shown to have diverse actions in the CNS. Although there has been considerable interest in the effects of nicotine and tobacco smoking in man and other species, the mechanisms and sites of action of nicotine in the brain are not clearly understood. It has been shown in many experiments that nicotine can influence behavior. Examples are the facilitatory effect of nicotine on self-stimulation,1 the dose-dependent facilitation of avoidance learning,2 the increased performance of learned tasks, and the decrease of task acquisition.3 Improved memory retention after nicotine administration has been suggested to be related to nicotine’s stimulant properties, altering the arousal state after training,4 and not to direct effects on the rate of protein synthesis. Although nicotine reverses the amnestic effects of cycloheximide treatment,5 reversal of the inhibition of protein synthesis is not involved.6 Nicotine increases the release of several biogenic amines and neuropeptides; release of norepinephrine and hydroxytryptamine is increased in brain homogenates,7 and release from the pituitary of ACTH8 and vasopressin9 is also increased. During fetal development, nicotine may affect brain function and development,10 possibly as a result of decreased protein synthesis.11,12
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Pradhan, S. N., and Bowling, C., 1971, J. Pharmacol. Exp. Ther. 176: 229–243.
Bovet, D., Bovet-Nitti, F., and Oliverio, A.. 1969, Science 163: 139–149.
Nelsen, J. M., 1974, Drug Addiction, Neurobiology and Influences on Behavior. Volume 3 (J. M. Singh and H. Lal, eds.), Grune and Stratton, New York, pp. 375–386.
Flood, J. F., Bennett. E. L., Orme. A. E., Rosenzweig, M. R., and Jarvik. M. E., 1978, Science 199: 324–326.
Stamm. E. R., and Schlesinger, K., 1980, J. Comp. Psychol. 94: 1184–1190.
Sershen, H., Reith, M. E. A., and Lajtha, A., 1982, Brain Res. 251: 183–185.
Balfour, D. J. K., 1973, Eur. J. Pharmacol. 23: 19–26.
Cam, G. R., Bassett, J. R., and Cairncross, K. D., 1979, Arch. Int. Pharmacodyn. Ther. 237: 49–66.
Reaves, T. A., Jr., Liu, H. M., Oasim, M., and Hayward, J. N., 1981, Peptides 2: 13–17.
Hudson, D. B., Meisami, E., and Timiras, P. S., 1973, Experientia 29: 286–288.
Sershen, H., and Lajtha, A., 1979, Neuropharmacology 18: 763–766.
Sershen, H., Reith, M. E. A., Banay-Schwartz, M., and Lajtha, A., 1982, Neurochem. Res. 7: 1515–1522.
Schleifer, L. S., and Eldefrawi, M. E.. 1974, Neuropharmacology 13: 53–63.
Abood, L. G., Lowy, K., Tometsko, A., and Booth, H., 1978, J. Neurosci. Res. 3: 327–333.
Yoshida, K., and Imura, H., 1979, Brain Res. 172: 453–459.
Vincek, W. C., Martin, B. R., Aceto, M. D., and Bowman, E. R., 1980, J. Med. Chem. 23: 960–962.
Romano, C., and Goldstein, A., 1980, Science 210: 647–650.
Sershen, H., Reith, M. E. A., Lajtha, A., and Gennaro, J., Jr., 1981, J. Receptor Res. 2: 115.
Marks, M. J., and Collins, A. C., 1982, Mol. Pharmacol. 22: 554–564.
Beckett, A. H., and Triggs, E. J., 1966, Nature 211: 1415–1419.
Feyerabend, C., and Russell, M. A. H., 1979, J. Pharm. Pharmacol. 31: 73–76.
Maskarinec, M. P., Harvey, R. W., and Caton, J. E., 1978, J. Anal. Toxicol. 2: 124–126.
Piade, J. J., and Hoffman, D., 1980, J. Liquid Chromatogr. 3: 1505–1515.
Hartvig, P., Ahnfelt, N.-O., Hammarlund, M., and Vessman, J., 1979, J. Chromatogr. 173: 127–138.
Feyerbend, C., Levitt, T., and Russell, M. A. H., 1975, J. Pharm. Pharmacol. 27: 434–437.
Castro, A., Monji, N., Malkus, H., Eisenhart, W., McKennis, H., Jr., and Bowman, E. R., 1979, Clin. Chini. Acta 95: 473–481.
Turner, D. M., 1969, Biochem. J. 115: 889–896.
Turner, D. M., 1971, Br. J. Pharmacol. 41: 521–529.
Turner, D. M., 1975. Xenobiotica 9: 553–561.
Miller, R. P., Rotenberg, K. S., and Adir, J., 1977, Drug Metab. Dispos. 5: 436–443.
McKennis, H., Jr., Turnbull, L. B.. Schwartz, S. L., Tamaki, E., and Bowman, E. R., 1962, J. Biol. Chem. 237: 541–546.
Oldendorf, W., Braun, L., and Cornford, E.. 1979, Stroke 10: 577–581.
Oldendorf, W. H., 1974, Proc. Soc. Exp. Biol. Med. 147: 813–816.
Yamamoto, I., Inoki, R., and Iwatsubo, K., 1968, Toxicol. Appl. Pharmacol. 12: 560–565.
Turner, D. M., 1969, Biochem. J. 115: 889–893.
Sershen, H., and Lajtha, A., 1979, J. Neurosci. Res. 4: 85–91.
Spector, R., and Goldberg, M. J., 1982, J. Neurochem. 38: 594–596.
Leeds, J., and Turner, D., 1977. Biochem. Pharmacol. 26: 1631–1635.
Balfour, D. J. K.. 1980. Arch. Int. Pharmacodyn. Ther. 245: 95–103.
Balfour, D. J. K., Khullar, A. K., and Longden, A., 1975, Pharmacol. Biochem. Behay. 3: 179–184.
Turner, D. M., 1975, Res. Commun. Chem. Pathol. Pharmacol. 12: 645–655.
Benwell, M. E. M., and Balfour, D. J. K., 1979, Psychopharmacology 63: 7–11.
Rowell, P. P., Hurst, H. E., Marlowe, C., and Bennett, B. D., 1983, J. Pharmacol. Methods 9: 249–261.
Hansson, E., and Schmiterlow, C. G., 1962, J. Pharmacol. Exp. Ther. 137: 91–102.
Russell, M. A. H., and Feyerbend, C., 1978, Drug Metab. Rev. 8: 29–35.
Driscoll, P., and Bättig, K., 1973, Rev. Environ. Health. 1: 113–133.
Morrison, C. F., and Armitage, A. K., 1967, Ann. N.Y. Acad. Sci. 142: 268–276.
Morrison, C. F., 1967, J. Neuropharmacol. 6: 229–240.
Pradhan, S. N., 1970, Arch. Int. Pharmacodyn. Ther. 183: 127–138.
Hanson, H. M., Ivester, C. A., and Morton. B. R., 1979, Cigarette Smoking as a Dependence Process (N. A. Krasnegor, ed.), NIDA Research Monograph, National Institute of Drug Abuse, Rockville, Maryland, pp. 1–39.
Domino, E. F., and Olds, M. E., 1968, J. Pharmacol. Ther. 164: 202–211.
Longo, V. G., Giunta, F., and Scotti de Carolis, A., 1967, Ann. N.Y. Acad. Sci. 142: 159–169.
Volle, R. L., and Koelle, G. B., 1965, The Pharmacological Basis of Therapeutics (L. S. Goodman and A. Gilman, eds.), Macmillan, New York, pp. 465–474.
Wesnes, K., Warbarton, D. M., and Matz, B., 1983, Neuropsychobiology 9: 41–44.
Wesnes, K., and Warbarton, D. M., 1983, Neuropsychobiology 9: 223–229.
Wesnes, K.. and Warbarton, D. M.. 1983, Neuropsychobiology 9: 154–157.
Lang, N. J., Latiff, A. A., McQueen, A., and Singer, A., 1977, Pharmacol. Biochem. Behan. 7: 65–70.
Smith, L. A., and Lang, W. J., 1980, Pharmacol. Biochem. Behay. 13: 215–220.
Griffiths, R. R., Brady, J. V., and Bradford. L. D., 1979, Advances in Behavioral Pharmacology, Volume 2 (T. Thompson and P. B. Dews, eds.), Academic Press, New York, pp. 162–208.
Goldberg, S. R., Spealman, R. D.. and Goldberg, D. M., 1981, Science 214: 573–575.
Dunn, W. L., 1978, International Workshop on Behavioral Effects of Nicotine (K. Bättig, ed.), S. Karger, Basel, pp. 38–55.
Hall, G. H., and Morrison, C. F., 1973, Nature 243: 199–201.
Hutchinson, R. R., and Emley, G. S., 1973, Smoking Behavior: Motives and Incentives (W. L. Dunn, ed.), V. H. Winston, Washington, pp. 171–196.
Driscoll, P., and Bättig, K., 1981, Pharmacol. Biochem. Behay. 14: 175–179.
Abood, L. G., Lowy, K., Tometsko, A., and MacNeil, M., 1979, Arch. Int. Pharmacodyn. Ther. 237: 213–229.
Abood. L. G., Lowy, K., Tometsko, A., and Booth, H., 1978, Neurosci. Res. 3: 327–333.
DeNoble, V. J., and Carron, L., 1981, Soc. Neurosci. 7: 662.
Caulfield, M. P., and Higgins. G. A., 1983, Neuropharrnacology 22: 347–351.
Phan, D. V., Doda, M., Bite, A., and Gyorgy, L., 1973, Acta Physiol. Acad. Sci. Hung. 1: 85–93.
Mattila, M. J., Ahtee, L., and Saarnivaara, L., 1977, Psychopharmacology 52: 7–15.
Sahley, T. L., and Bernston, G. G., 1979, Psychopharmacology 65: 279–283.
Brodie, B. B., and Hogben, A. M., 1957, J. Pharm. Pharmacol. 9: 345–380.
Tripathi, H. M., Martin, B. R., and Aceto, M. D., 1982, J. Pharmacol. Exp. Ther. 221: 9196.
Hughes, J., Kosterlitz, H. W., and Leslie, F. M., 1975, Br. J. Pharmacol. 242: 414–420.
Aceto, M. D., and Harris, L. S., 1981, Psychopharmacology of Clonidine (H. Lal and S. Fielding, eds.), Alan R. Liss, New York, pp. 243–256.
Bernston, G. G., and Berson, B. S., 1980, Life Sci. 26: 455–459.
Krivoy, W. A., Zimmerman, E., and Lande, S., 1974, Proc. Natl. Acad. Sci. 71: 1852–1856.
Bovet, D., Bovet-Nitti, F., and Oliverio, A., 1967, Ann. N.Y. Acad. Sci. 142: 261–267.
Bättig, K., Driscoll, P., Schlatter, J., and Uster, H. J., 1976, Pharmacol. Biochem. Behay. 4: 435–439.
Schlatter, J., and Bättig, K., 1979, Psychopharmacology 64: 155–161.
Morrison, C. F., 1967, J. Neuropharmacol. 6: 229–235.
Carr, L. A., and Moore, K. E., 1970, Biochem. Pharmacol. 19: 2361–2374.
Balfour, D. J. K., 1973, Ear. J. Pharmacol. 23: 19–26.
Glowinski. J., and Axelrod, J., 1965, J. Pharmacol. Exp. Ther. 149: 43–47.
Carlsson, A., Lindqvist, M., Dahlstrom, A., Fuxe, K.. and Masuoka, D., 1965, J. Pharm. Pharmacol. 17: 521–527.
Flood, J. F., Bennett, E. L., Orme, A. E., Rosenzweig, M. R., and Jarvik, M. E., 1978, Science 199: 324–326.
Flood, J. F., Jarvik, M. E., Bennett, E. L., Orme, A. E., and Rosenzweig, M. R., 1977, Behay. Biol. 20: 168–183.
Sershen, H., Reith, M. E. A., and Lajtha, A., 1982, Brain Res. 251: 183–185.
Armitage, A. K., Hall, G. H.. and Morrison, C. F., 1968, Nature 217: 331–334.
Chiou, C. Y., Long, J. P., Potrepka, R., and Spratt, J. L., 1970, Arch. Int. Pharmacodyn. Ther. 187: 88–96.
Balfour, D. J. K., 1982, Pharmacol. Ther. 16: 269–282.
Chang, P.-L., Bhagat, B., and Taylor, J. J., 1973, Brain Res. 54: 75–84.
Larsson, P.-A., Dahlstrom, A., Heiwall, P.-O., and Booj, S., 1980, J. Neural Transm. 47: 243–251.
GiOrguieff-Chesselet, M. F., Kernel, M. L., Wandscheer, D., and Glowinski, J., 1979, Life Sci. 25: 1257–1262.
Hall, G. H., and Turner, D. M., 1972, Biochem. Pharmacol. 21: 1829–1838.
Westfall, T. C., 1974, Neuropharmacology 13: 693–700.
Arqueros, L., Naquira, D., and Zunino, E., 1978, Biochem. Pharmacol. 27: 2667–2674.
Lichtensteiger, W., Felix, D., Lienhart, R., and Hefti, F., 1976, Brain Res. 117: 85–103.
Lichtensteiger, W., Felix, D., Hefti, F., and Schlumpf, M., 1979, Electrophysiological Effects of Nicotine (A. Remond and C. Izard, eds.), Elsevier, Amsterdam, pp. 15–30.
Lichtensteiger, W., Hefti, F., Felix, D., Huwyler, T., Melamed, E., and Schlumpf, M., 1982, Neuropharmacology 21: 963–968.
Connelly, M. S., and Littleton, J. M., 1983, J. Neurochem. 41: 1297–1302.
Kumakura, K., Karoum, F., Guideotta, A., and Costa, E., 1980. Nature 283: 489–492.
Kamerling, S. G., Wettstein, J. G., Sloan, J. W., Su, T.-P., and Martin, W. R., 1982, Pharmacol. Biochem. Behay. 17: 733–740.
Hendry, J. S., Rosecrans, J. A., Hong, J. S., and Bondy, S. C., 1982, Fed. Proc. 41: 4716.
Reaves, T. A., Jr., Liu, H.-M., Qasim, M., and Hayward, J. N., 1978, Soc. Neurosci. Abstr. 4: 353.
Bernston, G. G., and Berson, B. S., 1980, Life Sci. 26: 455–459.
Kelly, P. T., and Luttges, M. W., 1972, Neuropharmacology 11: 889–893.
Hamosh, M., Simon, M. R., and Hamosh, P., 1979, Biol. Neonate 35: 290–297.
Johns, J. M., Louis, T. M., Becker, R. F., and Means, L. W., 1982, Neurobehay. Toxicol. Teratol. 4: 365–369.
Peters, M. A., and Ngan, L. L. E., 1982, Arch. Int. Pharmacodyn. Ther. 257: 155–167.
Peters, D. A. V., Taub, H., and Tang, S., 1979, Neurobehay. Toxicol. 1: 221–225.
Sershen, H., Reith, M. E. A., Lajtha, A., and Gennaro, J., Jr. 1981, Neuropharmacology 20: 451–456.
Abood, L. G., Reynolds, D. T., and Bidlack, J. M., 1980, Life Sci. 27: 1307–1314.
Aceto, M. D., and Martin, B. R., 1982, Medicinal Research Review, Volume 2, John Wiley and Sons, New York.
Cheng, Y.-C., and Prusoff, W. H., 1973, Biochem. Pharmacol. 22: 3099–3108.
Schwartz, R. D., McGee, R., Jr., and Kellar, K. J., 1982, Mol. Pharmacol. 22: 56–62.
Abood, L. G., Latham, W., and Grassi, S., 1983, Proc. Natl. Acad. Sci. U.S.A. 80: 3536–3539.
Barnard, E. A., and Dolby, J. 0., 1982, Trends Neurosci. 5: 325–327.
Norman, R. T., Mehraban, F., Barnard, E. A., and Dolby, J., 1982, Proc. Natl. Acad. Sci. U.S.A. 79: 1321–1325.
Schwartz, R. D., and Kellar, K. J., 1983, Science 202: 214–216.
Marks, M. J., Burch, J. B., and Collins, A. C., 1983, J. Pharmacol. Exp. Ther. 226: 817–825.
Costa, L. G., and Murphy, S. D., 1983, J. Pharmacol. Exp. Ther. 226: 392–397.
Sloan, J. W., Martin, W. R., and Todd, G. D., 1983, Psychopharmacol. Bull. 19: 402–408.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sershen, H. (1985). Nicotine. In: Lajtha, A. (eds) Alterations of Metabolites in the Nervous System. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6740-7_10
Download citation
DOI: https://doi.org/10.1007/978-1-4757-6740-7_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-6742-1
Online ISBN: 978-1-4757-6740-7
eBook Packages: Springer Book Archive